Radiothérapie prostatique: Prédiction de la toxicité tardive à partir des données dosimétriques

Translated title of the contribution: Dosimetric factors predictive of late toxicity in prostate cancer radiotherapy

R. de Crevoisier, C. Fiorino, B. Dubray

Research output: Contribution to journalArticle

Abstract

Dose escalation in prostate cancer is made possible due to technological advances and to precise dose-volume constraints to limit normal tissue damage. This article is a literature review focusing on the correlations between exposure (doses and volumes) of organs at risk (OAR) and rectal, urinary, sexual and bone toxicity, as well as on mathematical models aiming at toxicity prediction. Dose-volume constraint recommendations are presented that have been shown to be associated with reduced rectal damage. Indeed, the clinical data is relatively strong for late rectal toxicity (bleeding), with constraints put on both the volume of the rectum receiving high doses (≥70 Gy) and the volume receiving intermediate doses (40 to 60 Gy). Predictive models of rectal toxicity (Normal Tissue Complication Probability) appear to accurately estimate toxicity risks. The correlations are much weaker for the bulb and the femoral heads, and nearly do not exist for the bladder. Further prospective studies are required, ideally taking into account patient-related risk factors (co-morbidities and their specific treatments), assays of normal tissue hypersensitivity to ionizing radiation and mathematical models applied on 3D images acquired under the treatment machine (e.g. Cone Beam CT).

Original languageFrench
Pages (from-to)460-468
Number of pages9
JournalCancer/Radiotherapie
Volume14
Issue number6-7
DOIs
Publication statusPublished - Oct 2010

Fingerprint

Prostatic Neoplasms
Radiotherapy
Theoretical Models
Organs at Risk
Cone-Beam Computed Tomography
Thigh
Ionizing Radiation
Rectum
Hypersensitivity
Urinary Bladder
Prospective Studies
Hemorrhage
Morbidity
Bone and Bones
Therapeutics

Keywords

  • Modelling
  • Normal tissue complications
  • Prostate
  • Radiotherapy

ASJC Scopus subject areas

  • Oncology
  • Radiology Nuclear Medicine and imaging
  • Medicine(all)

Cite this

Radiothérapie prostatique : Prédiction de la toxicité tardive à partir des données dosimétriques. / de Crevoisier, R.; Fiorino, C.; Dubray, B.

In: Cancer/Radiotherapie, Vol. 14, No. 6-7, 10.2010, p. 460-468.

Research output: Contribution to journalArticle

@article{078a0ace15684373b4e65d84a0f5337b,
title = "Radioth{\'e}rapie prostatique: Pr{\'e}diction de la toxicit{\'e} tardive {\`a} partir des donn{\'e}es dosim{\'e}triques",
abstract = "Dose escalation in prostate cancer is made possible due to technological advances and to precise dose-volume constraints to limit normal tissue damage. This article is a literature review focusing on the correlations between exposure (doses and volumes) of organs at risk (OAR) and rectal, urinary, sexual and bone toxicity, as well as on mathematical models aiming at toxicity prediction. Dose-volume constraint recommendations are presented that have been shown to be associated with reduced rectal damage. Indeed, the clinical data is relatively strong for late rectal toxicity (bleeding), with constraints put on both the volume of the rectum receiving high doses (≥70 Gy) and the volume receiving intermediate doses (40 to 60 Gy). Predictive models of rectal toxicity (Normal Tissue Complication Probability) appear to accurately estimate toxicity risks. The correlations are much weaker for the bulb and the femoral heads, and nearly do not exist for the bladder. Further prospective studies are required, ideally taking into account patient-related risk factors (co-morbidities and their specific treatments), assays of normal tissue hypersensitivity to ionizing radiation and mathematical models applied on 3D images acquired under the treatment machine (e.g. Cone Beam CT).",
keywords = "Modelling, Normal tissue complications, Prostate, Radiotherapy",
author = "{de Crevoisier}, R. and C. Fiorino and B. Dubray",
year = "2010",
month = "10",
doi = "10.1016/j.canrad.2010.07.225",
language = "Francese",
volume = "14",
pages = "460--468",
journal = "Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique",
issn = "1278-3218",
publisher = "Elsevier Masson",
number = "6-7",

}

TY - JOUR

T1 - Radiothérapie prostatique

T2 - Prédiction de la toxicité tardive à partir des données dosimétriques

AU - de Crevoisier, R.

AU - Fiorino, C.

AU - Dubray, B.

PY - 2010/10

Y1 - 2010/10

N2 - Dose escalation in prostate cancer is made possible due to technological advances and to precise dose-volume constraints to limit normal tissue damage. This article is a literature review focusing on the correlations between exposure (doses and volumes) of organs at risk (OAR) and rectal, urinary, sexual and bone toxicity, as well as on mathematical models aiming at toxicity prediction. Dose-volume constraint recommendations are presented that have been shown to be associated with reduced rectal damage. Indeed, the clinical data is relatively strong for late rectal toxicity (bleeding), with constraints put on both the volume of the rectum receiving high doses (≥70 Gy) and the volume receiving intermediate doses (40 to 60 Gy). Predictive models of rectal toxicity (Normal Tissue Complication Probability) appear to accurately estimate toxicity risks. The correlations are much weaker for the bulb and the femoral heads, and nearly do not exist for the bladder. Further prospective studies are required, ideally taking into account patient-related risk factors (co-morbidities and their specific treatments), assays of normal tissue hypersensitivity to ionizing radiation and mathematical models applied on 3D images acquired under the treatment machine (e.g. Cone Beam CT).

AB - Dose escalation in prostate cancer is made possible due to technological advances and to precise dose-volume constraints to limit normal tissue damage. This article is a literature review focusing on the correlations between exposure (doses and volumes) of organs at risk (OAR) and rectal, urinary, sexual and bone toxicity, as well as on mathematical models aiming at toxicity prediction. Dose-volume constraint recommendations are presented that have been shown to be associated with reduced rectal damage. Indeed, the clinical data is relatively strong for late rectal toxicity (bleeding), with constraints put on both the volume of the rectum receiving high doses (≥70 Gy) and the volume receiving intermediate doses (40 to 60 Gy). Predictive models of rectal toxicity (Normal Tissue Complication Probability) appear to accurately estimate toxicity risks. The correlations are much weaker for the bulb and the femoral heads, and nearly do not exist for the bladder. Further prospective studies are required, ideally taking into account patient-related risk factors (co-morbidities and their specific treatments), assays of normal tissue hypersensitivity to ionizing radiation and mathematical models applied on 3D images acquired under the treatment machine (e.g. Cone Beam CT).

KW - Modelling

KW - Normal tissue complications

KW - Prostate

KW - Radiotherapy

UR - http://www.scopus.com/inward/record.url?scp=77958176753&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77958176753&partnerID=8YFLogxK

U2 - 10.1016/j.canrad.2010.07.225

DO - 10.1016/j.canrad.2010.07.225

M3 - Articolo

C2 - 20797890

AN - SCOPUS:77958176753

VL - 14

SP - 460

EP - 468

JO - Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique

JF - Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique

SN - 1278-3218

IS - 6-7

ER -